298 related articles for article (PubMed ID: 30081934)
1. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
[TBL] [Abstract][Full Text] [Related]
2. The dietary flavonoid isoliquiritigenin induced apoptosis and suppressed metastasis in melanoma cells: An in vitro and in vivo study.
Xiang S; Zeng H; Xia F; Ji Q; Xue J; Ren R; Que F; Zhou B
Life Sci; 2021 Jan; 264():118598. PubMed ID: 33189818
[TBL] [Abstract][Full Text] [Related]
3. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S
Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.
Wu D; Chen B; Cui F; He X; Wang W; Wang M
Cell Prolif; 2016 Aug; 49(4):476-83. PubMed ID: 27352910
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice.
Wu CH; Chen HY; Wang CW; Shieh TM; Huang TC; Lin LC; Wang KL; Hsia SM
Oncotarget; 2016 Nov; 7(45):73432-73447. PubMed ID: 27708238
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.
Wang TT; Chen ZZ; Xie P; Zhang WJ; Du MY; Liu YT; Zhu HY; Guo YS
Eur J Pharmacol; 2019 Aug; 856():172352. PubMed ID: 31004603
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway.
Zhang XR; Wang SY; Sun W; Wei C
Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879
[TBL] [Abstract][Full Text] [Related]
9. Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells.
Wang Y; Ma J; Yan X; Chen X; Si L; Liu Y; Han J; Hao W; Zheng Q
Recent Pat Anticancer Drug Discov; 2016; 11(2):215-27. PubMed ID: 26951491
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signaling.
Chen XY; Li DF; Han JC; Wang B; Dong ZP; Yu LN; Pan ZH; Qu CJ; Chen Y; Sun SG; Zheng QS
Oncotarget; 2017 May; 8(21):34565-34575. PubMed ID: 28410220
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
12. Isoliquiritigenin suppresses the progression of malignant melanoma via targeting H2A.Z.1-E2F1 pathway.
Xiang S; Jian L; Zeng H; Wu H; Ge B; Zhang P; Lin J; Guo A; Zhou B
Biochem Pharmacol; 2023 Dec; 218():115859. PubMed ID: 37863326
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1.
Wang C; Chen Y; Wang Y; Liu X; Liu Y; Li Y; Chen H; Fan C; Wu D; Yang J
J Exp Clin Cancer Res; 2019 Aug; 38(1):371. PubMed ID: 31438982
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
[TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin inhibits the proliferation, apoptosis and migration of osteosarcoma cells.
Li C; Zhou X; Sun C; Liu X; Shi X; Wu S
Oncol Rep; 2019 Apr; 41(4):2502-2510. PubMed ID: 30720124
[TBL] [Abstract][Full Text] [Related]
16. MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.
Cao L; Liu Y; Wang D; Huang L; Li F; Liu J; Zhang C; Shen Z; Gao Q; Yuan W; Zhang Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):83. PubMed ID: 29661228
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression.
Wu F; Cui L
Arch Dermatol Res; 2017 Dec; 309(10):823-831. PubMed ID: 28936555
[TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
20. Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.
Chen C; Shenoy AK; Padia R; Fang D; Jing Q; Yang P; Su SB; Huang S
J Exp Clin Cancer Res; 2018 Oct; 37(1):243. PubMed ID: 30285892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
